Zhejiang Huahai Pharmaceutical (600521) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Zhejiang Huahai Pharmaceutical Company Snapshot

Business Description:

Zhejiang Huahai Pharmaceutical operates in the Pharmaceutical preparations sector. ZHEJIANGHUAHAIPHARMACEUTICALCO.,LTD is principally engaged in the manufacture and distribution of pharmaceutical ingredients, intermediates and preparations. The Company's major products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine hydrochloride tablets, risperidone tablets, fosinopril sodium tablets and irbesartan and hydrochlorothinzide tablets, among others. The Company also involves in provision of related technical support services. The Company distributes its products in domestic and overseas markets. In our complete report available for purchase the company is compared to: Jiuzhitang Company Limited, Hutchison China Meditech Limited and China Medical System Holdings Limited.

Zhejiang Huahai Pharmaceutical

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 10.97
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	16.1%

4 Weeks	-29.5%	52 Weeks	-12.7%

Zhejiang Huahai Pharmaceutical Key Data:

Ticker:	600521	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	1,022,845,000 (Year Ending Jan 2011).	Employees:	2,855

Currency:	Chinese Renmimbi	Market Cap:	5,908,521,916

Fiscal Yr Ends:	December	Shares Outstanding:	538,607,285

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.